Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from IDEAYA Biosciences, Inc.’s reported figures.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
FAQ
- What is IDEAYA Biosciences, Inc.'s EBIT?
- IDEAYA Biosciences, Inc. (IDYA) reported EBIT of -$108.54M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s EBIT changed year-over-year?
- IDEAYA Biosciences, Inc.'s EBIT decreased by 28.6% year-over-year, from -$84.39M to -$108.54M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s EBIT?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s EBIT has grown at a 33.4% compound annual growth rate (CAGR), from -$50.27M to -$159.31M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about IDEAYA Biosciences, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude